Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


oral

ORAL NUTRACEUTICALS

Project Design Planning

APR has experience in the oral nutraceutical formulations development; our approach united to our solid background permit us to give you the best and the most complete support starting from galenic phase to a complete Dossier ready for the Registration7Notification purpose. Before starting with the technical activities are necessary some steps in order to reduce risks of the development

view more



Integrated project development

The steps usually done for a complete development are the following:

view more


Search results